Bottom line
Is LVAQX a good fund? The bottom line
LVAQX is the Investor Class share class of LSV Small Cap Value Fund, an actively managed small-cap mutual fund from SEI.
Annual fees run 1.08% — about $108 a year on every $10,000 invested, more expensive than 58% of small-cap funds we track.
It returned +7.0% over one year, +11.3% a year over five years, +8.1% a year over ten (as of Dec 31, 2025, per its prospectus).
With $708 million in net assets and 228 holdings, its largest position is Jazz Pharmaceuticals Public Limited Company (1.7%) and the top 10 make up 11.1% of the portfolio.
What stands out
- 5-year return beat 92% of category peers
- Broadly diversified (228 holdings)
What to watch
- 12b-1 marketing fee of 0.25% a year
Updated Nov 19, 2026
What LVAQX invests in
The LSV Small Cap Value Funds (the Fund) investment objective is long-term growth of capital.
Under normal circumstances, the Fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of small-capitalization companies. This investment policy can be changed by the Fund upon 60 days prior written notice to shareholders. For purposes of this policy, a small-capitalization company is a company with a market capitalization of less than $2.5 billion, or the highest market capitalization in the Russell 2000 Value Index, whichever is greater, at the time of initial purchase. The Fund may also invest, to a lesser extent, in equity securities of companies with larger market capitalizations. The equity securities in which the Fund invests are mainly common stocks. In selecting securities for the Fund, the Adviser focuses on companies whose securities, in the Advisers opinion, are out-of-favor (undervalued) in the marketplace at the time…
From the fund's prospectus (filed Feb 27, 2026).
LVAQX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| LVAQX | +7.0% | +11.3% | +8.1% |
| Small-Cap median | +7.6% | +7.0% | +9.2% |
Source: Fund prospectus, as of Dec 31, 2025
What LVAQX costs
On a $10,000 investment, LVAQX's 1.08% expense ratio costs about $108 a year. The prospectus estimates $1,317 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.
LVAQX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Jazz Pharmaceuticals Public Limited Company | 1.70% |
| 2 | Cno Financial Group, Inc. | 1.24% |
| 3 | Exelixis, Inc. | 1.17% |
| 4 | Hf Sinclair Corporation | 1.06% |
| 5 | Popular, Inc. | 1.04% |
| 6 | Zions Bancorporation, National Association | 0.99% |
| 7 | Ugi Corporation | 0.98% |
| 8 | Oshkosh Corporation | 0.98% |
| 9 | Associated Banc-corp | 0.97% |
| 10 | The Bank of N.T. Butterfield & Son Limited | 0.94% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 11.1% of the fund. See all top 25 holdings and asset mix →